{"schema_version":"secwatch.filing_event.v1","accession":"0001625297-25-000072","form_type":"8-K","ticker":"INDV","cik":"0001625297","company_name":"Indivior Pharmaceuticals, Inc.","filed_at":"2025-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.966382+00:00","generated_at":"2026-05-16T13:13:14.332756+00:00","sec_items":["5.03","5.07","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"confidence":"high","headline":"Indivior shareholders approve scheme of arrangement to restructure, court hearing Jan 22, 2026","bullets":["Amended articles effective Dec 11 to facilitate scheme ensuring all shareholders become holders of Indivior Pharmaceuticals shares.","Court meeting: 94,968,161 votes for (99.9%) vs 46,544 against; passed by required majorities.","Extraordinary General Meeting: all 6 special resolutions passed with over 79 million votes for each.","Completion subject to High Court sanction hearing expected January 22, 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001625297-25-000072","json":"https://secwatch.observer/filing/0001625297-25-000072.json","markdown":"https://secwatch.observer/filing/0001625297-25-000072.md","text":"https://secwatch.observer/filing/0001625297-25-000072.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625297/000162529725000072/0001625297-25-000072-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625297/000162529725000072/indv-20251211.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:13:14.332756+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}